Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bivalirudin versus unfractionated heparin in transfemoral TAVR
NL-OMON27624Not yet recruiting
- Sponsor
- The Medicines Company
- Start
- Aug 2012
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of bivalirudin and heparin in aortic stenosis (AS) (3 arms), sponsored by The Medicines Company. Planned start Aug 2012; status: not yet recruiting.
02
Drugs
bivalirudinheparin
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on NL-OMON27624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27624.